$CTM

Ives Glen R purchased $772 of CTM

Ives Glen R (President) purchased 1,262 shares of Castellum, Inc. (CTM) at $0.61 on 2026-07-01.

Original reporting
SEC EDGAR · Ives Glen R
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CTM
Bullish
low confidence
Mentioned
$CTM
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTMBullishLow
01

Why it matters

The newest fact is the President’s open-market purchase details (shares, price, total value, and post-transaction holdings).

02

Market read

Traders may note mild sentiment from insider buying, but the disclosed transaction size is small and lacks fundamental follow-through.

03

What to watch

No 10b5-1 plan was cited, but the article does not provide context on prior holdings, compensation timing, or whether the buy was part of a broader pattern.

Relevance 4/10Novelty 3/10Timing: filed 2026-07-02, transaction dated 2026-07-01

Background

The article is an SEC Form 4 insider transaction disclosure for Castellum, Inc. (CTM).

Company-level read

Ticker impact

$CTMBullishLow confidence
Context

Castellum, Inc. Form 4 shows President Ives Glen R bought 1,262 shares at $0.6120 on 2026-07-01, totaling $772.34.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small given the transaction size.

Evidence & confidence

The filing is a primary-source insider transaction, but the dollar value ($772) is modest and there is no accompanying guidance, deal, or operational change disclosed.

Market effects

No clear sector read-through from a small, single-insider purchase.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine, tax-related, or opportunistic; a $772 purchase is unlikely to signal material change.

Key entities

  • Castellum, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Ives Glen R

    President of Castellum, Inc., reported an open-market purchase.

Related articles

$CTMMed

Castellum, Inc. (CTM): Results of Operations and Financial Condition

Castellum, Inc. (CTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991aug62026.htm EX-99.1 Document EXHIBIT 99.1 Castellum Announces Second Quarter and First Half 2026 Financial Results First Half 2026 Revenue Increased 10% to $28.2 Million; Expects Full Year 2026 to Be a Record Year in Terms of Revenue Debt-Free Balance Sheet w

$CTMMed

Canterra Minerals Commences Phase 2 Drill Program to Advance District-Scale Copper-Zinc Growth Strategy at Buchans, Newfoundland

Canterra Minerals (TSXV: CTM, OTCQB: CTMCF, FSE: DXZB) started an ~8,000 m Phase 2 diamond drill program at its Buchans copper-zinc district in Newfoundland, including ~2,000 m at the Lundberg deposit. The company aims to support a maiden Lundberg mineral resource estimate targeted for Q4 2026 and test satellite targets. It also reported ~$1.13M from warrant and option exercises.

$CTMMedAI 8/10

CTM uncovers Australian revenue errors dating back to 2019, delays financial statements

Corporate Travel Management (CTM) said in an ASX update that it has delayed lodgement of its overdue FY25 and first-half FY26 financial statements to August 2026. The audit found new issues: CTM expects to restate ANZ FY24 revenue by $10–15m, mainly from FY19–FY23 rebate accounting, and identified UK air booking margin contracts needing further review. CTM also disclosed goodwill impairments (GBP 92m Europe, AUD 77m ANZ, USD 49m North America) and ongoing lender discussions tied to a UK £118m ov